Federal Appeals Court Overturns Dismissal of Class Action Lawsuit Against Matrixx Initiatives

Symbols: MTXX
Posted in: News, FDA
Share

Federal Appeals Court overturns dismissal of class action lawsuit against Matrixx Initiatives (Nasdaq: MTXX). There is a class action lawsuit for people that were negatively affected by Matrixx's Zicam product.


 
 
< Previous
GMAC Seeks Fresh Lifeline
Next >
CIT Obtains An Additional $4.5B In Financing, Comments on Icahn
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust

Special Offers:
Quick Cash Advance